This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Apr;13(2):e002824.

doi: 10.1161/CIRCGEN.119.002824. Epub 2020 Jan 31.

Novel Missense Variant in MYL2 Gene Associated With Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology

Marzia De Bortoli^#^{1

2

3}, Riccardo Vio^#⁴, Cristina Basso⁴, Martina Calore^{1

5}, Giovanni Minervini⁶, Annalisa Angelini⁴, Paola Melacini⁴, Libero Vitiello^{1

7}, Giovanni Vazza¹, Gaetano Thiene⁴, Silvio Tosatto⁶, Domenico Corrado⁴, Sabino Iliceto⁴, Alessandra Rampazzo^{1

8}, Chiara Calore⁴

Affiliations

Affiliations

¹ Department of Biology (M.D.B., M.C., L.V., G.V., A.R.), University of Padua, Italy.
² Institute for Biomedicine, Eurac Research, Bolzano, Italy (M.D.B.).
³ Affiliated Institute of the University of Lübeck, Germany (M.D.B.).
⁴ Department of Cardiac, Thoracic, Vascular Sciences and Public Health (R.V., C.B., A.A., P.M., G.T., D.C., S.I., C.C.), University of Padua, Italy.
⁵ IMAiA-Institute for Molecular Biology and RNA Technology, Faculty of Science and Engineering, Faculty of Health, Medicine and Life Sciences, Maastricht University, the Netherlands (M.C.).
⁶ Department of Biomedical Sciences (G.M., S.T.), University of Padua, Italy.
⁷ Interuniversity Institute of Myology, Italy (L.V.).
⁸ CRIBI Biotechnology Centre (A.R.), University of Padua, Italy.

^# Contributed equally.

PMID: 32004434
DOI: 10.1161/CIRCGEN.119.002824

Novel Missense Variant in MYL2 Gene Associated With Hypertrophic Cardiomyopathy Showing High Incidence of Restrictive Physiology

Marzia De Bortoli et al. Circ Genom Precis Med. 2020 Apr.

. 2020 Apr;13(2):e002824.

doi: 10.1161/CIRCGEN.119.002824. Epub 2020 Jan 31.

Authors

Marzia De Bortoli^#^{1

2

3}, Riccardo Vio^#⁴, Cristina Basso⁴, Martina Calore^{1

5}, Giovanni Minervini⁶, Annalisa Angelini⁴, Paola Melacini⁴, Libero Vitiello^{1

7}, Giovanni Vazza¹, Gaetano Thiene⁴, Silvio Tosatto⁶, Domenico Corrado⁴, Sabino Iliceto⁴, Alessandra Rampazzo^{1

8}, Chiara Calore⁴

Affiliations

¹ Department of Biology (M.D.B., M.C., L.V., G.V., A.R.), University of Padua, Italy.
² Institute for Biomedicine, Eurac Research, Bolzano, Italy (M.D.B.).
³ Affiliated Institute of the University of Lübeck, Germany (M.D.B.).
⁴ Department of Cardiac, Thoracic, Vascular Sciences and Public Health (R.V., C.B., A.A., P.M., G.T., D.C., S.I., C.C.), University of Padua, Italy.
⁵ IMAiA-Institute for Molecular Biology and RNA Technology, Faculty of Science and Engineering, Faculty of Health, Medicine and Life Sciences, Maastricht University, the Netherlands (M.C.).
⁶ Department of Biomedical Sciences (G.M., S.T.), University of Padua, Italy.
⁷ Interuniversity Institute of Myology, Italy (L.V.).
⁸ CRIBI Biotechnology Centre (A.R.), University of Padua, Italy.

^# Contributed equally.

PMID: 32004434
DOI: 10.1161/CIRCGEN.119.002824

No abstract available

Keywords: atrial fibrillation; cardiomyopathies; disease; genes; prognosis.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information